168
Participants
Start Date
July 2, 2024
Primary Completion Date
June 3, 2025
Study Completion Date
June 3, 2025
TAK-861
Oral tablet.
Placebo
TAK-861-matching placebo tablet.
Takeda Site 33, Oslo
Takeda Site 37, Vitoria-Gasteiz
Takeda Site 23, Bern
Takeda Site 22, Barmelweid
Takeda Site 27, Bergen
Takeda Site 35, Barcelona
Takeda Site 34, Berlin
Takeda Site 38, Castellon
Takeda Site 49, Danville
Takeda Site 26, Schwerin
Takeda Site 10, Norfolk
Takeda Site 2, Denver
Takeda Site 24, Madrid
Takeda Site 1, Columbia
Takeda Site 3, Atlanta
Takeda Site 43, Toulouse
Takeda Site 4, Orlando
Takeda Site 25, Montpellier
Takeda Site 30, Bologna
Takeda Site 42, Cleveland
Takeda Site 6, Cincinnati
Takeda Site 41, Valencia
Takeda Site 5, St Louis
Takeda Site 40, Lyon
Takeda Site 29, Paris
Takeda Site 44, Dallas
Takeda Site 48, Phoenix
Takeda Site 18, Upland
Takeda Site 31, Santa Ana
Takeda Site 47, Regensberg
Takeda Site 39, Redwood City
Takeda Site 45, Boston
Takeda Site 21, Ottawa
Takeda Site 11, Toronto
Takeda Site 50, Montreal
Takeda Site 32, Rome
Takeda Site 16, Kurume-shi
Takeda Site 13, Kitakyushu-shi
Takeda Site 14, Fukuoka
Takeda Site 9, Kohoku
Takeda Site 7, Kumamoto
Takeda Site 17, Isahaya-shi
Takeda Site 15, Urasoe-Shi
Takeda Site 12, Yodogawa
Takeda Site 8, Bunkyo-ku
Takeda Site 19, Kodaira-shi
Takeda Site 20, Shibuya-ku
Takeda Site 28, Zwolle
Takeda Site 36, Barcelona
Takeda Site 51, Lugano
Takeda Site 46, Cambridge
Takeda Site 52, London
Takeda Site 53, London
Lead Sponsor
Takeda
INDUSTRY